Krka, d. d. (WSE: KRK)

Market Cap	18.46B
Revenue (ttm)	8.14B
Net Income (ttm)	1.54B
Shares Out	n/a
EPS (ttm)	49.99
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	Jul 23, 2024

Volume	13
Open	604.00
Previous Close	602.00
Day's Range	602.00 - 608.00
52-Week Range	461.00 - 660.00
Beta	0.53
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 14, 2024

About Krka, d. d.

Krka, d. d., a generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally. Its prescription pharmaceuticals include medicines for the treatment of cardiovascular, alimentary tract and metabolism, central nervous system, infections, oncology, and other diseases. The company also provides non-prescription products for oral cavity and pharynx; cough and cold; a...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1954
• Employees: 10,284
• Stock Exchange: Warsaw Stock Exchange
• Ticker Symbol: KRK

Financial Performance

In 2023, Krka, d. d.'s revenue was 1.81 billion, an increase of 5.18% compared to the previous year's 1.72 billion. Earnings were 313.95 million, a decrease of -13.58%.

Financial numbers in EUR